Quick Answer
Chemours Co reported Diluted EPS of $2.57 per share (loss) for fiscal year 2025.
Chemours Co Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.57 | -658.7% |
| 2024 | $0.46 | +127.1% |
| 2023 | -$1.70 | -146.6% |
| 2022 | $3.65 | +1.4% |
| 2021 | $3.60 | +172.7% |
| 2020 | $1.32 | +512.5% |
| 2019 | -$0.32 | -105.9% |
| 2018 | $5.45 | +39.4% |
| 2017 | $3.91 | +9675.0% |
| 2016 | $0.04 | +108.0% |
| 2015 | -$0.50 | -122.6% |
| 2014 | $2.21 | -5.6% |
| 2013 | $2.34 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.40 | +281.8% | +115.7% |
| June 30, 2025 | -$2.54 | -751.3% | -8366.7% |
| March 31, 2025 | -$0.03 | -108.3% | +86.4% |
| September 30, 2024 | -$0.22 | -375.0% | -156.4% |
| June 30, 2024 | $0.39 | +115.5% | +8.3% |
| March 31, 2024 | $0.36 | -62.5% | +350.0% |
| September 30, 2023 | $0.08 | -94.7% | +103.2% |
| June 30, 2023 | -$2.52 | -300.0% | -362.5% |
- Chemours Co showed a decrease of -658.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2013–2025 period, Chemours Co’s diluted eps has declined by 209.8% (from $2.34 per share to $2.57 per share (loss)).
- The most recent figure is from Chemours Co’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: